Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 546 | $485.11 | $264.9K | -7.0% | Open the original filing on SEC.gov |
| Feb 18 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 638 | $473.68 | $302.2K | -7.6% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,557 | $489.46 | $762.1K | -15.7% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 598 | $483.75 | $289.3K | -5.7% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT◷ | 1,809 | — | — | +20.7% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 1,393 | $487.76 | $679.4K | -13.8% | Open the original filing on SEC.gov |
| Feb 11 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,376 | $460.43 | $633.6K | -12.0% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 592 | $468.41 | $277.3K | -4.9% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 1,300 | — | — | +12.0% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 2,950 | — | — | +37.6% | Open the original filing on SEC.gov |